Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep-Dec;8(3):283-90.
doi: 10.4103/0259-1162.143110.

Ketamine: Current applications in anesthesia, pain, and critical care

Madhuri S Kurdi  1 , Kaushic A Theerth  1 , Radhika S Deva  1
Affiliations
Review

Ketamine: Current applications in anesthesia, pain, and critical care

Madhuri S Kurdi et al. Anesth Essays Res. 2014 Sep-Dec.

Abstract

Ketamine was introduced commercially in 1970 with the manufacturer's description as a "rapidly acting, nonbarbiturate general anesthetic" and a suggestion that it would be useful for short procedures. With the help of its old unique pharmacological properties and newly found beneficial clinical properties, ketamine has survived the strong winds of time, and it currently has a wide variety of clinical applications. It's newly found neuroprotective, antiinflammatory and antitumor effects, and the finding of the usefulness of low dose ketamine regimens have helped to widen the clinical application profile of ketamine. The present article attempts to review the current useful applications of ketamine in anesthesia, pain and critical care. It is based on scientific evidence gathered from textbooks, journals, and electronic databases.

Keywords: Anesthesia; clinical applications; critical care; drug; ketamine; pain; palliative care; pediatrics; perioperative analgesia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Reves JG, Glass PS, Lubarsky DA, McEvoy MD, Ruiz RM. Intravenous anaesthetics. In: Miller RD, editor. Miller's Anaesthesia. 7th ed. USA: Churchill Livingstone; 2010. pp. 719–71.
    1. White PF, Elig MR. Intravenous anaesthetics. In: Barash PG, editor. Clinical Anaesthesia. 6th ed. China: Lippincott Williams and Wilkins; 2013. pp. 478–500.
    1. Stoelting RK, Hillier SC. Nonbarbiturate intravenous anaesthetic drugs. In: Stoelting RK, Hillier SC, editors. Pharmacology and Physiology in Anaesthetic Practice. 4th ed. Philadelphia: Lippincott Williams and Wilkin; 2006. pp. 155–78.
    1. Advisory Council on the Misuse of Drugs. Ketamine: A review of use and harm, 2013. Report. [Last accessed on 2014 Jul 08]. Available from: http://www.gov.uk/government/./ACMD_ketamine_report_dec13.pdf .
    1. Persson J. Wherefore ketamine? Curr Opin Anaesthesiol. 2010;23:455–60. - PubMed